Early trial tests how body handles new stomach ulcer drugs
NCT ID NCT07385235
Summary
This early-stage study aims to understand how the body processes and tolerates two different versions of an experimental gastric ulcer drug. It will involve about 46 healthy adults who will take each formulation once. The main goal is to compare the drug levels in the blood and check for safety, not to treat ulcers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.